Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants
Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Dowling, G., ... & Halberstadt, A. L. | Drug testing and analysis | 18 June 2018
Replication and extension of a model predicting response to psilocybin
Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. | Psychopharmacology | 15 June 2019
Acute subjective and behavioral effects of microdoses of LSD in healthy human volunteers
Bershad, A. K., Schepers, S. T., Bremmer, M. P., Lee, R., & de Wit, H. | Biological Psychiatry | 3 June 2019
‘Never drop without your significant other, cause that way lies ruin’: The boundary work of couples who use MDMA together.
Anderson, K., Reavey, P., & Boden, Z. | International Journal of Drug Policy | 3 June 2019
Motives and side-effects of microdosing with psychedelics among users
Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | International Journal of Neuropsychopharmacology | 31 May 2019
Psychedelic-assisted therapies: The past, and the need to move forward responsibly.
Gardner, J., Carter, A., O’Brien, K., & Seear, K. | International Journal of Drug Policy | 25 May 2019
Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin
Lord, L. D., Expert, P., Atasoy, S., Roseman, L., Rapuano, K., Lambiotte, R., & Cabral, J. | NeuroImage | 25 May 2019
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.
Jefsen, O., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D. J., Wegener, G., & Müller, H. K. | Acta neuropsychiatrica | 20 May 2019
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model
Nemes, B., Pető, K., Németh, N., Mester, A., Magyar, Z., Ghanem, S., Bidiga, L. | Transplantation proceedings | 15 May 2019
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Garcia-Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 14 May 2019
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., ... & Doblin, R. | Psychopharmacology | 7 May 2019
Narrative identity, rationality, and microdosing classic psychedelics
Webb, M., Copes, H., & Hendricks, P. S. | International Journal of Drug Policy | 6 May 2019
Effects of MDMA on attention to positive social cues and pleasantness of affective touch.
Bershad, A. K., Mayo, L. M., Van Hedger, K., McGlone, F., Walker, S. C., & de Wit, H. | Neuropsychopharmacology | 30 April 2019
100 years of mescaline
Jay, M. | Monatshefte für Chemie-Chemical Monthly | 29 April 2019
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.
Holze, F., Duthaler, U., Vizeli, P., Müller, F., Borgwardt, S., & Liechti, M. E. | British journal of clinical pharmacology | 29 Apr 2019
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.
Rocha, J. M., Osório, F. L., Crippa, J. A. S., Bouso, J. C., Rossi, G. N., Hallak, J. E., & dos Santos, R. G. | Therapeutic advances in psychopharmacology | 26 April 2019
Dimethyltryptamine: Endogenous Role and Therapeutic Potential.
Rodrigues, A. V., Almeida, F. J., & Vieira-Coelho, M. A. | Journal of psychoactive drugs | 25 April 2019
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport
Coleman, J. A., Yang, D., Zhao, Z., Wen, P. C., Yoshioka, C., Tajkhorshid, E., & Gouaux, E. | Nature | 24 April 2019
Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. | PloS one | 23 April 2019
Psychedelics as a treatment for disorders of consciousness
Scott, G., & Carhart-Harris, R. L. | Neuroscience of consciousness | 21 April 2019
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care.
Rosa, W. E., Hope, S., & Matzo, M. | Journal of Holistic Nursing | 18 April 2018
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019